Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127767512 | 12776751 | 2 | F | 20160915 | 20160923 | 20160925 | EXP | PHHY2016US128079 | SANDOZ | 12.00 | YR | M | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127767512 | 12776751 | 1 | SS | METHYLPHENIDATE HYDROCHLORIDE. | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | 36 MG, QD (ONCE IN MORNING) | Y | 0 | 36 | MG | QD | ||||||
127767512 | 12776751 | 2 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 875 MG, QD (375 MG Q AM AND 500 MG AT BEDTIME) | Y | 78290 | 875 | MG | TABLET | QD | |||||
127767512 | 12776751 | 3 | SS | PAROXETINE. | PAROXETINE | 1 | Unknown | 40 MG, QD (EVERY MORNING) | Y | 0 | 40 | MG | QD | ||||||
127767512 | 12776751 | 4 | SS | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | Unknown | 0.125 MG, QD (AT BEDTIME) | Y | 0 | .125 | MG | QD | ||||||
127767512 | 12776751 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG, BID | Y | 0 | .5 | MG | BID | ||||||
127767512 | 12776751 | 6 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 1.5 MG, QD (0.5 MG QAM AND 1MG AT BEDTIME) | Y | 0 | 1.5 | MG | QD | ||||||
127767512 | 12776751 | 7 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG, UNK | Y | 0 | .5 | MG | |||||||
127767512 | 12776751 | 8 | C | MELATONIN | MELATONIN | 1 | Unknown | 5 MG, QD (AT BEDTIME AS NEEDED) | Y | 0 | 5 | MG | QD | ||||||
127767512 | 12776751 | 9 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Unknown | U | 0 | ||||||||||
127767512 | 12776751 | 10 | C | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | U | 0 | ||||||||||
127767512 | 12776751 | 11 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127767512 | 12776751 | 1 | Product used for unknown indication |
127767512 | 12776751 | 2 | Product used for unknown indication |
127767512 | 12776751 | 3 | Product used for unknown indication |
127767512 | 12776751 | 4 | Product used for unknown indication |
127767512 | 12776751 | 5 | Product used for unknown indication |
127767512 | 12776751 | 8 | Sleep disorder |
127767512 | 12776751 | 9 | Evidence based treatment |
127767512 | 12776751 | 10 | Evidence based treatment |
127767512 | 12776751 | 11 | Evidence based treatment |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127767512 | 12776751 | LT |
127767512 | 12776751 | HO |
127767512 | 12776751 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127767512 | 12776751 | Agitation | |
127767512 | 12776751 | Anxiety | |
127767512 | 12776751 | Chills | |
127767512 | 12776751 | Constipation | |
127767512 | 12776751 | Decerebrate posture | |
127767512 | 12776751 | Dysarthria | |
127767512 | 12776751 | Dysphagia | |
127767512 | 12776751 | Hyperhidrosis | |
127767512 | 12776751 | Muscle rigidity | |
127767512 | 12776751 | Neuroleptic malignant syndrome | |
127767512 | 12776751 | Opisthotonus | |
127767512 | 12776751 | Salivary hypersecretion | |
127767512 | 12776751 | Tachycardia | |
127767512 | 12776751 | Tachypnoea | |
127767512 | 12776751 | Tremor | |
127767512 | 12776751 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |